| Line Item | 2026-01-03 | Y/Y |
|---|---|---|
| Revenue | $52.7M | +8.2% |
| Cost of Revenue | $33.4M | +14.7% |
| Gross Profit | $19.2M | -1.4% |
| R&D Expense | $3.7M | -32.7% |
| SG&A Expense | $7.7M | -20.9% |
| Operating Income | -$2.6M | +69.0% |
| Interest Expense | $58K | -60.3% |
| Pre-tax Income | -$4.4M | +50.5% |
| Income Tax | $57K | -16.2% |
| Net Income | -$4.4M | +50.2% |
| EPS (Basic) | -$0.26 | +51.9% |
| EPS (Diluted) | -$0.26 | +51.9% |
| Line Item | 2026-01-03 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.0M | +152.5% |
| Accounts Receivable | $7.6M | +27.9% |
| Inventory | $7.9M | -27.2% |
| Current Assets | $25.3M | +7.2% |
| Total Assets | $29.2M | +0.1% |
| Current Liabilities | $13.2M | -20.2% |
| Long-term Debt | $1.0M | +0.0% |
| Total Liabilities |
| Line Item | 2026-01-03 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.1M | +71.0% |
| Capital Expenditures | $143K | +1000.0% |
| Investing Cash Flow | -$143K | -1000.0% |
| Financing Cash Flow | $6.0M | +128.9% |
| Free Cash Flow | -$2.3M | +69.1% |
| $24.2M |
| -10.4% |
| Stockholders' Equity | $4.9M | +134.7% |